SCHEMBL25753261

SCHEMBL25753261

Cc1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc(-c5cccc(-c6cccc7c6sc6c(-c8ccccc8)cccc67)c5)nc4c3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.49
KDM4E B2RXH2 8/20 0.49
NPC1 O15118 8/20 0.49
SMN1; SMN2 Q16637 8/20 0.49
HPGD P15428 6/20 0.49
CASP3 P42574 2/20 0.49
SENP8 Q96LD8 2/20 0.49
SENP7 Q9BQF6 2/20 0.49
SENP6 Q9GZR1 2/20 0.49
POLB P06746 1/20 0.49
ALDH1A1 P00352 7/20 0.45
TP53 P04637 4/20 0.45
HSD17B10 Q99714 4/20 0.45
MAPT P10636 5/20 0.45
NFKB1 P19838 4/20 0.45
NFKB2 Q00653 4/20 0.45
RELA Q04206 4/20 0.45
L3MBTL1 Q9Y468 3/20 0.43
GLA P06280 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25459500 0.95 HPSE (0.43) RAB9AKDM4ENPC1SMN1; SMN2HPGD
SCHEMBL25459432 0.89 TP53 (0.43) RAB9AKDM4ENPC1SMN1; SMN2HPGD
SCHEMBL21890976 0.89 HPSE (0.46) RAB9AKDM4ENPC1SMN1; SMN2HPGD
SCHEMBL25459498 0.88 ALOX5 (0.46) RAB9AKDM4ENPC1SMN1; SMN2HPGD
SCHEMBL25459696 0.86 VSIR (0.44) RAB9AKDM4ENPC1SMN1; SMN2HPGD
SCHEMBL25459429 0.86 NPC1 (0.44) RAB9AKDM4ENPC1SMN1; SMN2HPGD
SCHEMBL25459436 0.85 HPSE (0.40) RAB9AKDM4ENPC1SMN1; SMN2HPGD
SCHEMBL23473581 0.84 NPC1 (0.43) RAB9AKDM4ENPC1SMN1; SMN2HPGD
SCHEMBL25459644 0.83 NPC1 (0.44) RAB9AKDM4ENPC1SMN1; SMN2HPGD
SCHEMBL25459495 0.82 NPC1 (0.44) RAB9AKDM4ENPC1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX RAB9A 3117/4885KDM4E 2446/4885NPC1 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.